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Chitin is a N-acetyl-d-glucosamine biopolymer that can be recognized by chitin-binding 
proteins. Although mammals lack chitin synthase, they induce proteins responsible for 
detecting chitin in response to bacterial infections. Our aim was to investigate whether 
chitinase 3-like 1 (CHI3L1) has a potential role in the innate immunity of the Escherichia 
coli (E. coli) infected mammary gland. CHI3L1 protein was found to be secreted in whey 
of naturally coliform-affected quarters compared to whey samples isolated from healthy 
udders. In addition, gene expression of CHI3L1 was confirmed in udder tissue of cows 
experimentally infected with a mammary pathogenic E. coli (MPEC) strain. Despite the 
known anatomical differences, the bovine udders’ innate immune response was mimi-
cked by applying an experimental mouse model using MPEC or non-MPEC isolates. The 
effect of CHI3L1 expression in the murine mammary gland in response to coliform bacteria 
was investigated through the use of CHI3L1−/− mice as well as through treatment with 
either a pan-caspase inhibitor or chitin particles in wild-type mice. The local induction of 
CHI3L1 postinfection with different E. coli strains was demonstrated to be independent 
of both bacterial growth and mammary interleukin (IL)-8 levels. Indeed, CHI3L1 emerged 
as a regulator impacting on the transcytosis of Ly6G-positive cells from the interstitial 
space into the alveolar lumen of the mammary tissue. Furthermore, CHI3L1 was found 
to be upstream regulated by caspase activity and had a major downstream effect on the 
local pro-inflammatory cytokine profile, including IL-1beta, IL-6, and RANTES/CCL5. In 
conclusion, CHI3L1 was demonstrated to play a key role in the cytokine and caspase 
signaling during E. coli triggered inflammation of the mammary gland.
Keywords: chitinase 3-like 1, Escherichia coli, bovine mastitis, immunomodulation, mouse mammary gland 
infection model
inTrODUcTiOn
Chitin is a prominent polymer present within the cuticle of arthropods, plays a crucial part of cephalo-
pods and the cell wall of fungi, but is absent in mammals (1–3). Chitin consists of a repetitive linear 
chain of β-1,4 linked N-acetyl-d-glucosamine units. As potential microbial-associated molecular 
pattern, mammals have the ability to either bind or process chitin by using the number-18 glycoside 
Table 1 | Primers used for RT-qPCR.
gene Forward primer  
sequence 5′–3′
reverse primer  
sequence 5′–3′
IL-1beta CTCTCACAGGA 
AATGAACCGAG
GCTGCAGGGTG 
GGCGTATCACC
IL-6 TGCTGGTCTTCT 
GGAGTATC
GTGGCTGGAGT 
GGTTATTAG
IL-8 TGAAGCTGCAG 
TTCTGTCAAG
TTCTGCACCCAC 
TTTTCCTTGG
Chitinase 3-like 1 TCTGTTGGAGGA 
TGGAACTTCG
TGGCACCGACTT 
GATGAAAG
18S CGGGGAGGTAGT 
GACGAAA
CCGCTCCCAAGA 
TCCAACTA
ACTB ACGGGCAGGTCA 
TCACCATC
AGCACCGTGTTG 
GCGTAGAG
PPIA TCCGGGATTTATGT 
GCCAGGG
GCTTGCCATCCAA 
CCACTCAG
2
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hydrolase (GH18) family, which can be divided into two subfa-
milies: chitinase-like proteins (CLPs), which bind chitin but do 
not possess chitinolytic activity and chitinases, which bind chitin 
and subsequently hydrolyze their substrate (4).
Mammals use the chitin recognition machinery to protect 
themselves against pathogenic chitinous species (5, 6). Members 
of the GH18 family detect chitin in pathogenic organisms and trigger 
expression and activation of mammalian chitinase(-like) proteins, 
which have been implicated in the inflammatory response against 
these organisms (7). Interestingly, mammalian CLPs are also induced 
in response to chitin-lacking bacterial pathogens (8) and even to non-
infectious diseases like cancer (9–14). In response to lung infections 
or bone marrow-derived macrophages, chitinase 3-like 1 (CHI3L1) 
participates in the immune defense and bacterial clearance through 
inhibition of caspase-1-dependent macrophage pyroptosis (15, 16). 
These observations imply that mammalian chitinase(-like) proteins 
are likely to play a key role of the hosts’ (innate) immune response 
(17, 18). However, the underlying molecular mechanism in which 
these proteins are involved remains poorly understood.
Chitinase(-like) proteins have been analyzed in extracellular 
fluids, such as milk (19, 20). In the mammary tissue, they have 
been implicated in different processes such as mammary involu-
tion, tumor development, epithelial apoptosis, and inflammation 
(21–23). The mammary inflammatory response is of crucial 
importance for dairy cattle to cope with udder infections (24) and 
is one of the three most important factors affecting cow replace-
ment in dairy herds. CLPs have been found in the udder secretions 
collected during the non-lactating period, in colostrum but not 
in normal milk (25, 26). Interestingly, however, a few proteome 
studies reported elevated levels of CLPs in normal milk upon 
mastitis (27–31). Yet, the biological role of these proteins during 
bovine mastitis remains unknown so far.
Our main aim was to investigate the potential role of CHI3L1 
during coliform mastitis and assess its contribution to the innate 
immune response in the infected mammary gland. For this purpose, 
the levels of the CHI3L1 protein were assessed in whey from healthy 
and naturally mastitis-affected cows by Western blot as well as 
mRNA expression in udder tissue of cows experimentally infected 
with Escherichia coli. Subsequently, a bovine coliform mastitis was 
simulated through an established murine mastitis model using 
E. coli isolates from clinical cases of bovine mastitis. The concen-
tration of CHI3L1 was determined together with key infection or 
inflammation parameters at the local level (bacterial load, neutro-
phil influx, interleukin (IL)-8 and IL1beta, IL-6, RANTES/CCL5 
levels). Third, in this validated murine mastitis model, the effects 
of CHI3L1 induction on up-/or downstream molecules were evalu-
ated using either CHI3L1-deficient mice or different treatments that 
have been shown to influence CHI3L1 in other mouse models, such 
as pan-caspase inhibition (15) and chitin treatment (10).
MaTerials anD MeThODs
Preparation of Whey Protein Fraction 
From Milk samples
Bovine milk samples were obtained from naturally coliform-
affected quarters (n = 6) and from healthy quarters (n = 3). Milk 
was centrifuged at 1,500 g for 20 min at 4°C to discard the fatty 
layer. The skimmed milk was then ultra-centrifuged for 1  h at 
53,300 g at 4°C to pellet casein micelles. The protein concentration 
in the samples was determined spectrophotometrically (Genesys 
10UV, Analis) using Bradford Protein Assay.
Western blotting analysis
Bovine whey proteins were loaded in equal amounts (72 µg pro-
tein per lane) on a 8–16% gradient polyacrylamide Amersham 
ECL Gel (GE Healthcare). After separation, proteins were trans-
ferred to a 0.45-µm nitrocellulose transfer membrane (Biorad). 
To detect bovine CHI3L1, the membranes were blocked in 
Tris-Buffered Saline (TBS) supplemented with 0.1% Tween-20 
(v/v), 0.1% bovine serum albumin, and 4% (w/v) non-fat dry milk 
and incubated overnight at 2–8°C on a platform shaker with a 
rabbit anti-bovine CHI3L1 polyclonal/monoclonal antibody 
(1.5  mg ml−1), kindly provided by Tom Wheeler, AgResearch, 
diluted 1:1,000 in TBS supplemented as described (31). Next, the 
membranes were washed in TBS (3 times for 5 min), and mem-
branes were probed using a donkey anti-rabbit IgG Horseradish 
Peroxidase-conjugated polyclonal antibody (1 mg ml−1, Thermo 
Fisher Scientific, diluted 1:20,000) for 60 min at room temperature 
(RT). The resulting CHI3L1 bands were visualized with Western 
Lightning™ Chemiluminescence Reagent Plus (PerkinElmer) on 
autoradiographic films (Amersham).
rT-qPcr analysis of chi3l1 Transcripts  
in Mammary Tissue From infected cows
RNA was extracted from mammary gland tissue of German 
Holstein Friesian cows (n = 5) in mid-lactation, experimentally 
infected with E. coli strain 1303 as described previously (32) 
using Trizol (Invitrogen). Experimental infection of animals was 
conducted at the Clinic for Ruminants (Munich, Germany) with 
the approval of the ethics committee of the regional government 
of upper Bavaria, Germany (No. 55.2-1-54-2531-108-05). Total 
RNA (1 µg) was reverse transcribed to cDNA using the iScript™ 
Reverse Transcription Supermix (Biorad). Quantitative PCR was 
then performed using the iQ SYBR Green Supermix (Biorad), 
using the primers listed in Table 1. Briefly, after normalization 
using the expression of three reference genes (ActB, PPIA, 18S 
RNA), expression of each gene was calculated using the Genex 
3Breyne et al. CHI3L1 Signaling in Coliform Mastitis
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macro (Biorad) relative to the values obtained from uninfected 
cows arbitrarily set to 1.
E. coli Murine intramammary infection 
Model
The in  vivo effect of the clinical bovine mastitis isolates E. coli 
O32:H37 strain P4 and E. coli O70:H32 strain 1303, alone or in 
combination with a treatment was evaluated using a murine 
intramammary infection model. Approval number EC2016/56 
was obtained from the Animal Ethics committee (Faculty of 
Veterinary Medicine, Merelbeke, Belgium). In brief, C57BL/6 
(n  =  28), CHI3L1−/− (also C57BL/6 background, n  =  6), and 
CD-1 (n = 33) dams were utilized 12–14 days (d) after birth of 
the offspring. Wild-type mice were purchased from Envigo and 
CHI3L1−/− mice were obtained from Prof. Jack A. Elias (Brown 
University). The CHI3L1−/− mice were originally generated in 
C57BL6/J cells and have been maintained on a C57BL6/J strain 
of mice (33). All inoculations were performed 2 h post-weaning 
under anesthesia. A mixture of oxygen and isoflurane (2–3%) was 
used for inhalational anesthesia of the lactating mice combined 
with a long-acting analgesic buprenorphine, intraperitoneally 
injected (at 10 µg kg−1 Vetergesic®, Patheon UK Ltd.). A syringe 
with a 32-gauge blunt needle (Thiebaud Biomedical Devices) was 
used to inoculate both L4 (on the left) and R4 (on the right) glands 
of the fourth abdominal mammary gland pair with approximately 
1,000 colony forming units (CFU) of E. coli resuspended in phos-
phate buffered saline (PBS). Each orifice was exposed by a small cut 
at the near end of the teat and 100 µl of the inoculum was injected 
slowly through the teat canal. When necessary, chitin particles 
were instilled into the mammary gland of anesthetized mice using 
the desired dose (approximately 106 particles in 200 µl of PBS per 
gland) at 4 h after bacterial inoculation. To test the effect of local 
caspase inhibiton on CHI3L1 induction, Z-VAD-fmk (Abcam) 
was dissolved into DMSO and diluted in PBS to a concentration of 
2.5% DMSO. When required, the R4 mammary gland was used for 
an intramammary injection (250 µl) with Z-VAD-fmk (correspond-
ing to 350 mg kg−1) while L4 was used for a sham (2.5% DMSO) 
treatment of E. coli P4 infected mammary glands at 4 h p.i. (34).
24 h p.i., all mice were sedated by administering a mixture of 
ketamine (at 100 mg kg−1 Anesketin, Eurovet Animal Health BV) 
with xylazine (at 10  mg  kg−1; Xylazini Hydrochloridum, Val 
d’Hony-Verdifarm) intraperitoneally and subsequently eutha-
nized by cervical dislocation. The mammary glands (two per 
mouse), which are physiologically separated and thus were con-
sidered as individual samples, were harvested and divided for 
the different analyses. For CFU and protein assays, mammary 
gland tissue was weighed and homogenized using a tissueruptor 
(QIAGEN Benelux BV). Bacterial CFU counts were obtained by 
standard plating on tryptic soy agar (Oxoid).
h&e histology, TUnel assay,  
and immunohistochemistry
Two mammary glands per condition were fixed in buffered 
3.5% formaldehyde for 24  h at RT and embedded in paraffin 
wax. Sections were deparaffinized, hydrated, and stained with 
hematoxylin and eosin. Subsequently, sections were rehydrated 
and mounted on a glass-slide and covered with a coverglass.
Apoptosis was quantitated in the mammary glands treated with 
Z-VAD-fmk and PBS-diluted DMSO (sham) by using the termi-
nal deoxynucleotidyl transferase-mediated deoxyuridine triphos-
phate nick-end labeling (TUNEL) assay. This specific assay uses 
terminal deoxynucleotidyl transferase to attach fluorescein labeled 
deoxyuridine triphosphate to free 3′-OH DNA ends. Sections 
of 5 µm were prepared from paraffin-embedded tissues using a 
microtome and placed on APES (3-Aminopropyltriethoxysilane)-
coated glass slides. The sections were deparaffinized in xylene and 
dehydrated in ethanol. The sections were incubated with a com-
mercial proteinase K kit (DAKO, Danmark) diluted in TE-buffer 
(Tris-EDTA; pH 8) for 15 min at RT. After rinsing the specimen 
twice with PBS, the sections were processed following the instruc-
tion of a commercial kit (In Situ Cell Death Fluorescein Detection 
Kit; Roche Applied Science, Shanghai, China). Sections were 
counterstained with Hoechst to visualize the nuclei. The TUNEL-
positive cells were identified as green fluorescein staining nuclei. 
The number of TUNEL-positive cells was counted in 20 random 
microscopic fields (40×).
Immunohistochemical stainings for Ly6G were performed on 
2- to 3-µm paraffin sections. The tissue slides were deparaffinized 
and incubated with citrate buffer (pH 6, containing 10 mM tri-
sodium citrate and 0.05% Tween-20) in a pressurized decloacking 
chamber at 95°C for 30 min. Blocking of endogenous peroxidase 
activity was performed by incubating the slides in a mixture of 
3% H2O2 in methanol for 10 min. Primary rat anti-mouse Ly6G 
antibody (clone 1A8, BioLegend, diluted 1:1,000 in antibody 
diluent from Dako) was applied on the tissue slides for 1 h at RT. 
Secondary rat-on mouse HRP-Polymer (Biocare Medical) was then 
applied for 30 min at RT. Final detection of antibody staining was 
established by incubation of the tissue slides in a buffer containing 
3,3′-diaminobenzidine for 10 min at RT. All incubation steps were 
performed in a humidified chamber on an orbital shaker. Rinsing 
of the slides in between incubation steps was performed with TBS. 
Quantification of immunohistochemical stainings was performed 
using Image J (3 color split and automatic cell counting).
Preparation of chitin Particles
A chitin particle emulsion was prepared as previously described 
with minor alterations (35). Briefly, chitin powder (Sigma-Aldrich) 
was suspended at 10 mg ml−1 in PBS (Thermo Fisher scientific) 
and sonicated with an ultrasonic probe sonifier 450 (VWR, 
Branson Ultrasonics). The solution was filtered through a 10-µm 
strainer (pluriSelect), pelleted after centrifugation (250 g, 10 min) 
and finally suspended in PBS. The size and amount of the chitin 
particles in the obtained pellet was verified by flow cytometry 
(FACSCanto, BD Biosciences) using BD Trucount beads (8 µm) 
and Cytometric Bead Array beads (3 µm). The size of the chitin 
particles in the gained suspension ranged between 3 and 8 µm.
cytokine Multiplex assay, chitinases 
activity assay, and chi3l1 elisa
One hundred microliters of mouse mammary gland homogenate 
were mixed with 300 µl lysis buffer supplemented with protease 
inhibitors (200 mM NaCl, 10 mM Tris–HCl pH 7.4, 5 mM EDTA, 
1% Nonidet P-40, 10% glycerol, 1  mM oxidized l-glutathion, 
100 µM PMSF, 2.1 µM leupeptin, and 0.15 µM aprotinin) to extract 
FigUre 1 | Chitinase 3-like 1 (CHI3L1) in coliform-infected bovine samples. (a) Bovine CHI3L1 protein detection in whey isolated from naturally coliform-infected 
cows (n = 6) compared to whey isolated from healthy quarters (n = 3). (b) interleukin (IL)-1beta, IL-6, IL-8, and CHI3L1 expression in Escherichia coli 1303 
experimentally infected cows (n ≥ 4). Data are presented as means ± SEM, indicating significant differences with *(P < 0.05).
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cellular proteins. The suspensions rested overnight at −20°C, were 
centrifuged at 12,250 g for 1 h and finally the supernatant was 
centrifuged for another 30 min to precipitate the pellet. Protein 
concentration of the lysate samples was determined as previously 
described (36). Cytokine quantification (ProcartaPlex from eBio-
science), chitinase assays (Sigma), and CHI3L1 ELISA (Biotechne) 
on the mammary gland lysates were all performed according to 
the manufacturer’s instructions. Briefly, chitinase activity assay 
determines exo- and endochitinase activity through the produc-
tion of fluorogenic products. The exochitinase activity releases 
one N-acetyl-d-glucosamine residue from the (non)reducing 
end, and can be measured with an artificial substrate such as 
4-methylumbelliferyl (MU) N,N′-diacetyl-β-d-chitobiose, while 
the endochitinase activity prefers longer N-acetyl-d-glucosamine 
chains and can, therefore, be measured with substrates such as 
4-MU N,N′,N′′-triacetyl-β-d-chitotriose (11).
statistical analysis
Statistical analysis was performed using Prism (GraphPad) and 
SPSS (IBM Analytics). Data were checked for normality and an 
unpaired Student’s t-test was used to determine whether differ-
ences between groups were statistically significant (P < 0.05).
resUlTs
chi3l1 is Present in Whey From naturally 
coliform-infected Udder Quarters  
and expressed in experimentally  
E. coli-infected Udder Quarters
Whey obtained from milk samples of dairy cows diagnosed with 
coliform mastitis (n = 7) were analyzed for the presence of CHI3L1. 
Rather than using an uncharacterized bovine ELISA, a previously 
characterized primary antibody against bovine CHI3L1 (31) was 
used for CHI3L1 detection in coliform-infected samples (n = 6). 
In five out of six coliform whey samples, it showed a strong signal 
by Western blotting while this 39-kDa protein band was absent in 
all whey samples obtained from bacteriologically negative quarter 
milk (n = 3) (Figure 1A; Figure S1 in Supplementary Material).
Following experimental infection of cows (different animals 
than those used for Western blotting analysis) with the bovine 
E. coli 1303 mammary pathogenic E. coli (MPEC) strain, IL- 
1beta, IL-6, IL-8, and CHI3L1 mRNA expression levels in these 
udder quarters were compared with those from uninfected 
quarters from the same cows (internal controls) and quarters of 
uninfected cows (external controls, data not shown). Compared 
to expression levels in uninfected quarters, E. coli 1303 infection 
significantly induced IL-1beta, IL-6, and IL-8 concomitantly with 
CHI3L1 in these infected quarters (Figure 1B).
In addition to CHI3L1 expression, chitinolytic activity is also 
of interest during coliform mastitis. Whey samples from coliform-
affected quarters showed significantly higher exochitinase and 
endochitinase activities compared to those from healthy quarters 
(Figure S2A in Supplementary Material).
chi3l1 is induced independently of the 
Mammary bacterial loads and il-8 levels 
in a Murine Mastitis Model
The observations in coliform-infected dairy cows were mim-
icked by experimentally infecting the mammary gland of 
C57BL/6 mice (inoculum dose =  103  CFU) with two E. coli 
strains P4 and 1303, isolated from acute cases of bovine mastitis, 
both belonging to phylogroup A (37, 38). Two non-MPEC E. 
coli strains (i.e., K-12 strains DH5alpha and MG1655) that also 
belong to phylogroup A, were inoculated at the same dose and 
alongside the MPEC E. coli strains P4 and 1303. At 24  h p.i., 
high bacterial loads were observed in the mammary glands with 
significantly different bacterial counts between E. coli strain P4 
and 1303 infected glands (9.64 ±  0.26 and 7.84 ±  1.70 log10 
CFU/g mammary gland, respectively) (Figure 2A). Both these 
FigUre 2 | Mammary chitinase 3-like 1 (CHI3L1) during mammary pathogenic E. coli (MPEC) and non-MPEC infections in the mouse mastitis model. (a) Bacterial 
loads in the mammary gland at 24 h p.i. with MPEC strains Escherichia coli P4 and 1303 compared to non-MPEC strains E. coli K12 strains DH5alpha and MG1655, 
and phosphate buffered saline (PBS) controls (n ≥ 8). (b) Histology of mammary tissue at 24 h p.i. with MPEC strains E. coli P4 and 1303, and non-MPEC strains E. coli 
K12 strains DH5alpha and MG1655 compared to PBS controls. (c) Association of IL-8 levels and bacterial loads in mammary tissue at 24 h p.i. with MPEC strains  
E. coli P4 and 1303, and non-MPEC strains E. coli K12 strains DH5alpha and MG1655 (n ≥ 7; r = 0.63; P < 0.01; 95% C.I. 0.354–0.808). (D) CHI3L1 levels in protein 
lysates extracted from mammary tissue at 24 h p.i. with MPEC strains E. coli P4 and 1303, and non-MPEC strains E. coli K12 strains DH5alpha and MG1655 compared 
to PBS controls (n ≥ 8). Data are presented as means ± SEM, indicating significant differences with *(P < 0.05); **(P < 0.01) or ***(P < 0.001). ns, not significant.
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non-MPEC strains yielded significantly lower bacterial loads 
compared to the two MPEC strains. Mammary gland infection 
with both MPEC strains was characterized by a high influx of 
immune cells in the alveolar lumen compared to PBS (sham) 
inoculated glands, whereas both non-MPEC strains also induced 
an immune cell recruitment albeit limited compared to the two 
MPEC strains (Figure 2B). Comparison of bacterial loads and 
IL-8 levels showed that E. coli strains with high bacterial loads 
correlated with mammary IL-8 levels (Pearson’s correlation 
r =  0.63, P <  0.01, 95% C.I. 0.354–0.808) (Figure  2C). This 
strongly positive correlation can be interpreted as a tendency for 
high CFU values that go with high IL-8 levels (and vice versa). 
In marked contrast to the latter observation, similar mammary 
CHI3L1 levels were observed after infection with either MPEC 
or non-MPEC strains compared to PBS inoculated (sham) 
mammary glands (Figure 2D).
chi3l1 is required for neutrophil influx  
in the alveolar lumen and influences a 
selected Panel of Mammary cytokines  
in the Mouse E. coli Model for Mastitis
Current literature on CHI3L1 in the mammary gland focuses on 
its role during breast cancer development. In order to decipher 
its immunological role during mammary infection, CHI3L1 
knock-out (CHI3L1−/−) and wild-type (CHI3L1+/+) animals were 
at first intramammarily inoculated with either PBS or E. coli P4 
(Figure 3A). Bacterial loads, IL-8, CHI3L1, and RANTES/CCL5 
levels were determined in CHI3L1−/− versus CHI3L1+/+ mice. At 
24  h p.i., bacterial loads and IL-8 levels significantly increased 
in the mammary gland independent of CHI3L1 in clear contrast 
to mammary RANTES/CCL5 levels that were significantly 
reduced in CHI3L1−/− compared to CHI3L1+/+ mice (Figure 3A). 
Moreover, CHI3L1 also influenced the levels of some other pro-
inflammatory cytokines. In contrast to RANTES/CCL5, IL-1beta 
and IL-6 protein levels in mammary tissue homogenates were 
significantly increased at 24 h p.i. in CHI3L1−/− mice compared 
to CHI3L1+/+ mice (Figure 3B). Histology showed striking dif-
ferences between CHI3L1−/− and CHI3L1+/+ mammary glands at 
24 h p.i. (Figure 3C). Immunostaining against Ly6G, a marker 
predominantly present on neutrophils, showed that neutrophils 
infiltrated the lumen of the mammary alveoli of the infected 
CHI3L1−/− mice (Figure  3D). However, the majority of these 
innate immune cells were still present in the interstitial space 
between the alveoli. This key observation was in marked contrast 
to infected CHI3L1+/+ glands where only a limited number of 
immune cells could be observed in the interstitial space and the 
majority was present in the alveolar lumen (Figure 3D).
FigUre 3 | Downstream effects of mammary chitinase 3-like 1 (CHI3L1) during Escherichia coli P4 infections in the mouse mastitis model. (a) Bacterial loads 
(n ≥ 12), and interleukin (IL)-8 (n ≥ 3), CHI3L1 (n ≥ 5), and RANTES/CCL5 levels (n ≥ 3) in the mammary glands of CHI3L1+/+ and CHI3L1−/− mice 24 h p.i. with  
E. coli P4. (b) IL-1beta (n ≥ 3) and IL-6 levels (n ≥ 3) in the mammary gland of CHI3L1+/+ and CHI3L1−/− mice 24 h p.i. with E. coli P4. (c) H&E histology of 
mammary tissue 24 h p.i. with E. coli P4 in CHI3L1+/+ and CHI3L1−/− mice. Black arrow illustrates the presumed neutrophilic innate immune cells (based on their 
characteristic polymorphonuclear morphology) in the interstitial space. (D) Immunohistochemical stainings for Ly6G on paraffin slides of mammary glands at 24 h 
p.i. with E. coli P4 or phosphate buffered saline (PBS) in CHI3L1+/+ and CHI3L1−/− mice. Black arrows indicate Ly6G-positive neutrophils in the interstitial space.  
Scale bars = 20 µm. The bar graphs display the quantified percentage of Ly6G-positive cells in the interstitial space versus the luminal space for stained sections  
of E. coli P4-infected mammary glands from CHI3L1+/+ and CHI3L1−/− mice (n ≥ 2 glands). Data are presented as means ± SEM, indicating significant differences 
with **(P < 0.01) or ***(P < 0.001). ns, not significant.
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Pan-caspase inhibition and chitin 
Treatment Decrease Mammary chi3l1 
During E. coli P4 infection in a Mouse 
Mastitis Model
Our data are in accordance to previous observations stating that 
IL-1beta signaling influences neutrophil trapping in the inters-
titial space of the infected mammary gland (39). To assess the 
effect of IL-1beta activators, such as caspase-1 and caspase-11, 
on CHI3L1 in the mammary gland, mice were intramammarily 
inoculated with E. coli P4 and then treated with a single bolus of 
either the pan-caspase inhibitor (Z-VAD-fmk) or DMSO (sham) 
administered via the same route at 4 h p.i. As indirect parameter 
supporting the (partly) inhibitory effect of local Z-VAD-fmk 
treatment on caspase function, a TUNEL assay was performed 
on mammary gland sections of wild-type mice intramammarily 
infected with E. coli P4 (Figure S4 in Supplementary Material). 
Histology of these E. coli-infected mammary glands treated with 
Z-VAD-fmk contained on average 47% less TUNEL-positive 
cells compared to the sham-treated mammary glands condition. 
Mammary CHI3L1 levels significantly decreased upon pan-
caspase inhibition compared to DMSO (sham) treatment, 
independently of bacterial loads and IL-8 levels at 24  h p.i. 
(Figure  4A). Concomitantly, RANTES/CCL5 levels were also 
significantly decreased at 24  h p.i. (Figure  4A). However, the 
decrease in CHI3L1 after treatment with Z-VAD-fmk was not 
FigUre 4 | Upstream regulators of mammary chitinase 3-like 1 (CHI3L1) during Escherichia coli P4 infections in the mouse mastitis model. (a) Bacterial loads 
(n = 5), and interleukin (IL)-8 (n = 5), CHI3L1 (n ≥ 4), and RANTES/CCL5 levels (n = 5) in the E. coli P4-infected mammary glands of mice treated with Z-VAD-fmk or 
DMSO (sham) at 24 h p.i. (b) Bacterial loads (n ≥ 12), and IL-8 (n ≥ 8), CHI3L1 (n = 6), and RANTES/CCL5 levels (n = 6) in the mammary gland of mice treated with 
chitin or phosphate buffered saline (PBS) controls at 24 h p.i. with E. coli P4. (c) IL-17A (n = 6), IL-4 (n = 6), and MCP-1 levels (n = 6) in the E. coli P4-infected 
mammary gland of mice treated with chitin or PBS controls at 24 h p.i. Data are presented as means ± SEM, indicating significant differences with *(P < 0.05); 
**(P < 0.01); or ***(P < 0.001). ns, not significant.
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strong enough to induce an effective neutrophil trapping. Indeed, 
the presence of Ly6G-positive cells in the interstitial space of 
mammary glands infected with E. coli was less evident following 
the Z-VAD-fmk treatment (white arrows in Figure 5) compared 
to clear observations in the CHI3L1−/− mice. Nonetheless, in 
our DMSO control (sham) no interstitial immune cells could be 
visualized (Figure 5).
Intraperitoneal administration of chitin particles to mammary 
tumor-bearing mice has been demonstrated to significantly 
reduce local CHI3L1 levels (10). To test the effect of local chitin 
particle treatment on CHI3L1 induction during experimental 
mastitis, mammary glands were inoculated with E. coli P4 (inocu-
lum dose = 103 CFU), followed by intramammary application of 
either chitin particles or PBS (sham) 4 h p.i. Mammary CHI3L1 
and RANTES/CCL5 levels significantly decreased upon chitin 
treatment compared to PBS (sham) treatment, independently of 
bacterial loads and IL-8 levels at 24 h p.i. (Figure 4B). Mammary 
levels of selected pro-inflammatory cytokines IL-17A, IL-4, and 
MCP-1/CCL2 also significantly decreased upon chitin treatment 
compared to PBS (sham) treatment at 24  h p.i. (Figure  4C). 
Although chitin treatment had a larger impact on the cytokine 
profiles in comparison to caspase inhibition, the Ly6G-positive 
cells were still able to cross the epithelial barrier (Figure  5). 
However, these migrated neutrophils were rather observed on 
the extremities of the alveolar lumen (white arrows in Figure 5) 
and more specifically around bacterial clusters (black arrows in 
Figure 5) but were absent in our PBS (sham) controls (Figure 5).
In addition to its inhibitory effect on the main chitinase-like 
family member (CHI3L1), chitin treatment also decreased the 
mammary chitinolytic activity at 24  h p.i. (Figures S2B,C in 
Supplementary Material). The E. coli P4-infected glands showed 
a significant increase in chitinolytic activity as measured both 
with N,N′-diacetyl-β-d-chitobiose and N,N′,N′′-triacetyl-β-d-
chitotriose substrates compared to the PBS (sham) inoculated 
mammary glands (Figure S2B in Supplementary Material). However, 
following chitin particle treatment, the fluorescent signal produced 
by cleavage of both the 4-MU N,N′-diacetyl-β-d-chitobiose and 
4-MU N,N′,N′′-triacetyl-β-d-chitotriose significantly decreased 
at 24 h p.i. (Figure S2C in Supplementary Material).
Finally, it was also verified whether the observed inhibitory 
effect of chitin treatment on local CHI3L1 induction was mouse 
strain-dependent. Mammary glands of CD-1 outbred mice were 
infected with E. coli P4 and subsequently treated with either chitin 
particles or PBS (sham) at 4 h p.i. Again, a significant decrease in 
FigUre 5 | Ly6G immunohistochemistry in Escherichia coli P4-infected mammary glands posttreatment with active substances or sham controls. 
Immunohistochemical stainings for Ly6G on paraffin slides of E. coli P4-infected mammary glands treated with Z-VAD-fmk, DMSO, chitin, or phosphate buffered 
saline (PBS). White arrows indicate Ly6G-positive neutrophils. Black arrows indicate bacterial clusters. Scale bars = 20 μm. The bar graph displays the quantified 
percentage of Ly6G-positive cells in the interstitial space versus the luminal space for stained sections of E. coli P4-infected mammary glands treated with DMSO  
or Z-VAD-fmk (n = 2 glands). Data are presented as means ± SEM.
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mammary CHI3L1 levels was observed as a consequence of the 
chitin particle treatment compared to a PBS (sham) treatment 
(Figure S3B in Supplementary Material). Again, this decrease was 
dependent on the dose of chitin used but not related to the bacte-
rial loads (Figure S3A in Supplementary Material). Additionally, 
chitin treatment of E. coli P4 infected animals again decreased the 
exo- and endochitinase activities (Figure S3C in Supplementary 
Material).
DiscUssiOn
Induction of inflammation is a crucial initializing step in bovine 
coliform mastitis (40, 41). Nonetheless, the contribution of both 
host and bacterial factors to initiation, progression and resolution 
of inflammation remains poorly characterized. Among proteins 
receiving recent attention are inflammatory mediators, such 
as CHI3L1, and its regulatory role in the host innate immune 
response are increasingly studied.
A wide variety of host innate immune cells, including neutro-
phils, monocytes/macrophages, and some epithelial cell lines can 
either express CHI3L1 or are affected by this regulatory protein 
through its binding to IL-13 Receptor α2 (18, 21, 42–47). As 
coliform mastitis involves the interplay of resident and infiltrating 
innate immune cells, our observations of significantly increased 
CHI3L1 protein levels and CHI3L1 transcription in both udders 
natural and experimental infected with E. coli compared to healthy 
quarters are in line with these data. Nevertheless, CHI3L1 has 
been only scarcely reported in some proteomic studies on bovine 
mastitis samples obtained from either natural or experimentally 
coliform-infected cows (27–29). As these studies are typically 
descriptive, the function of chitinase(-like) proteins in the context 
of bovine mastitis remains largely unclear.
Strains belonging to E. coli phylogroup A are most frequently 
isolated from coliform mastitis cases (48). Therefore, we used 
here the mouse mastitis model to mimic the marked induction 
of mammary CHI3L1 in cows by performing experimental intra-
ductal infections with two bovine phylogroup A mastitis isolates, 
E. coli P4 and 1303 (49, 50). Interestingly, CHI3L1 was equally 
induced at 24 h p.i. by both these MPEC strains, although infec-
tion with E. coli P4 yielded significantly higher bacterial loads, 
IL-8 levels, and subsequent neutrophil recruitment compared to 
E. coli 1303 infection. Two non-MPEC strains of phylogroup A 
(K-12 strains DH5alpha and MG1655) yielded significantly lower 
bacterial loads and concomitant IL-8 levels at 24 h p.i. compared 
to the two MPEC strains. Again, infection status had a marked 
correlation with IL-8, but not CHI3L1 levels were seen between 
the four E. coli infection groups.
To subsequently further assess potential molecules co-
regulated by/with CHI3L1, we next used CHI3L1-deficient mice 
in the context of mammary gland infection to corroborate our 
observations. Similar to our findings using whey and mammary 
tissue, we demonstrated a remarkable trapping of neutrophils in 
the interstitium of E. coli P4-infected CHI3L1−/− mice, which was 
associated with an aberrant induction of the pro-inflammatory 
mediator RANTES/CCL5. Nevertheless, although the latter 
cytokine is known as a leukocyte recruiter, its precise function 
in the mammary gland is currently unknown (51). Interestingly, 
we observed further that the lack of the CHI3L1-RANTES/CCL5 
axis was associated with a significant increase of the two key 
pro-inflammatory cytokines IL-1beta and IL-6. These data are 
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in agreement with the observation that the lack of IL-1 receptor 
signaling is related to an inefficient neutrophil recruitment into 
the alveolar lumen during endotoxin-induced mastitis (39, 52). 
Furthermore, a lack of CHI3L1 has been reported to be respon-
sible for an increase of IL-1beta during lung infection in mouse 
models (15, 16). CHI3L1 has been shown to contribute to the 
facilitation of bacterial invasion into the intestinal mucosa as well 
as to the development of acute colitis with E. coli strains distinct 
from mastitis strains (53). Thus, when carefully extrapolating 
such a direct effect of CHI3L1 to the context of E. coli mammary 
gland infections, targeting the CHI3L1 signaling pathway may 
open new avenues for future research regarding the modulation 
of the host immune response to coliform mastitis. Our findings 
on the immunomodulatory function of mammary CHI3L1 
complement the previously described function of a related mam-
malian CLP, stabilin-1 interacting CLP, that binds endotoxin and 
neutralizes the effect of this major E. coli virulence factor on the 
hosts’ tissue (54).
To gain insight in the signaling of CHI3L1 in the mammary 
gland, we subsequently explored the regulatory aspects of this 
protein. At 1 day after experimental MPEC mammary infection, 
local IL-1beta levels significantly increased in CHI3L1−/− com-
pared to CHI3L1+/+ mice. As the classical maturation of pro-
IL1beta to IL-1beta occurs via caspase-1, this key finding suggests 
a possible link between CHI3L1 and caspase activation in the 
E. coli-infected mammary gland. Supporting this hypothesis, we 
previously reported a non-classical, caspase-independent cleav-
age of pro-IL1beta to IL-1beta in the mammary gland of E. coli 
P4 infected CHI3L1+/+ mice (55). In line with our current obser-
vation in CHI3L1-deficient mice, a Streptococcus pneumoniae 
infection also induced higher levels of IL-1beta in BAL fluid of 
CHI3L1−/− compared to CHI3L1+/+ mice (15). The latter authors 
linked their finding to the CHI3L1-dependent regulation of a 
caspase-1 and Nlpr3 inflammasome, or vice versa (15). Therefore, 
a pan-caspase inhibitor was subsequently used to identify at first 
the probable location of caspases in the CHI3L1 signaling during 
coliform induced mammary inflammation in mice. This informa-
tion would inform us whether CHI3L1 is responsible for the neu-
trophil influx into the alveolar lumen independently of IL-1beta 
signaling previously reported (39). The observation that the num-
ber of cells containing double-stranded DNA breaks was reduced 
due to local Z-VAD-fmk treatment, is indicative for the fact that 
in vivo apoptosis was affected by this pan-caspase inhibitor (56). 
As this reduction is an indirect read-out for a decreased activity of 
apoptotic caspases, it can be further assumed that also caspase-1 
and -11, both mediators of pro-IL1beta maturation, might—at 
least partly—have been inhibited by Z-VAD-fmk. Furthermore, 
Ly6G immunohistology data showed less prominent neutrophil 
trapping compared to our observations with CHI3L1−/− mice. 
Together, these findings imply that both IL-1beta and CHI3L1 
are important for the neutrophils to cross the epithelial barrier 
during mammary inflammation.
Alternatively, CHI3L1 levels can also be modulated through 
interaction with chitin. The detailed inhibitory mechanism of 
CHI3L1 through chitin remains to be unraveled, it is known that 
chitin selectively and strongly binds to CLPs through a carbohy-
drate-binding motif (CBM) in its C-terminus (57). The loss of this 
CBM motif or a mutation herein either eliminates or decreases 
CHI3L1-induced cell signaling in colonic epithelial cells (57, 58). 
This mechanism was also suggested through the in vivo blockage 
of the CBM with a specific anti-CHI3L1, which facilitated dextran 
sulfate sodium-induced colitis (53). In that belief, we instilled chi-
tin particles directly into the target tissue to block the CBM of local 
CHI3L1 in the mastitic mouse mammary gland. This immuno-
modulation concept was adapted from a recent breast cancer 
report that also could lower local CHI3L1 levels, albeit through 
the intraperitoneal administration of chitin particles in mammary 
tumor-bearing mice (10). Our experiments now extend these data 
indicating that, similar as seen with the pan-caspase inhibition, 
local chitin particle treatment as expected significantly reduces the 
mammary levels of CHI3L1 but more importantly also causes less 
activation of local RANTES/CCL5. However, these changes did not 
affect bacterial loads nor local activation of IL-8. In comparison to 
the observations in CHI3L1−/− mice, the influx of neutrophils into 
the luminal space was less affected compared to caspase inhibitor 
or chitin treatment. The former treatment is in line with our previ-
ous observations that caspase activity is only partly responsible for 
proIL-1beta maturation in the inflamed mammary gland (55). 
Moreover, the trapping of immune cells observed in inflamed 
mammary glands of IL-1beta−/− animals is also less evident (39). 
Interestingly, although interstitial neutrophils could still cross the 
epithelial barrier after pretreatment with chitin, their influx was 
disturbed and led to bacterial clusters embedded in these neutro-
phils. This observation may be indicative for the fact that chitin has 
another mechanism than mere inhibition of CHI3L1.
In the current study, local chitin particle treatment was 
observed to lower also the mammary chitinolytic activity in 
our mouse model for bovine coliform mastitis. These additional 
chitin-binding proteins were not considered in the mammary 
tumor paper (10). We demonstrated at first that both in cows 
and in mice the chitinase activity is induced by coliform mastitis. 
In the cow genome, the G18 family consists of three chitinases, 
i.e., CTBS, AMCase, and CHIT1 (4). CTBS is an exochitinolytic 
member cleaving the disaccharide N,N′-diacetyl-β-d-chitobiose 
and the trisaccharide N,N′,N′-triacetyl-β-d-chitotriose of GlcNAc 
polymers (59). The in vivo function of CTBS activity in the mam-
mary gland is unclear. It has been suggested to have a general 
immunological function through cleavage of target glycosylated 
proteins in lysosomes, but it also modified glycoproteins in 
breast milk and in a bovine kidney cell line (60–62). The two 
other chitinases, CHIT1 and AMCase, have endochitinolytic 
activity and are, therefore, able to digest natural chitin as well 
as artificial chitobiose and chitotriose substrates (63). The endo-
chitinase activity was predominantly studied in airway patholo-
gies because the major chitinolytic activity is observed in the 
lung. Intranasal delivery of chitin induced an accumulation of 
immune cells which was mainly dependent on AMCase (64), 
while an increased asthma risk is suggested to be primarily the 
consequence of CHIT1 polymorphisms (11).
In analogy with CHI3L1, chitinases also contain a CBM. 
Currently, the consequences of inhibiting CBM-induced signal-
ing in chitinases are still poorly understood. Alternative splicing 
observed in human macrophage CHIT1 resulted in a truncated 
isoform lacking the CBM which was unable to bind chitin, but 
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was still able to hydrolyze chitotriose (65). In line with these data, 
we speculate that CBM signaling—both in the non-lytic chitin-
binding proteins like CHI3L1 and in the chitinases—is blocked 
by the chitin particle treatment rather than a direct inhibition 
of chitinolytic activity. Modulation upon chitin treatment of 
the cytokine profile—additional to the one associated with the 
CHI3L1-RANTES/CCL5 axis—would then be a result of the 
reduced chitinase signaling. Moreover, chitin and AMCase have 
been shown to influence macrophage activation and the accumu-
lation of IL-4 expressing innate immune cells in allergy models 
(64). Chitinases enhanced MCP-1 and increased the migratory 
capacity of macrophages in a blood–brain barrier in vitro model. 
Finally, it should be remarked that RANTES/CCL5 is also known 
to be induced by chitinases (66, 67), while CHI3L1 can induce 
macrophage recruitment by MCP-1 chemotaxis in colorectal 
cancer and has a role in IL-17A-dependent mechanisms (68, 69).
In conclusion, immunomodulatory treatments targeting to 
alter the levels and/or function of local chitinase(-like) proteins 
may offer a novel strategy to reduce the use of antibiotics in 
the dairy industry especially in the field of E. coli mammary 
gland infections, where antibiotic treatment remains the major 
intervention to date (70, 71). Our study partly unraveled some 
innovative aspects of this immunomodulation axis of CHI3L1 
during coliform mammary infection. As CHI3L1 has an impor-
tant Th2 modulating immunity function through IL-13 Rα2 
(33, 47), it is likely that this protein is also of key importance in 
later time points post-infection with either E. coli or even with 
chronic mastitis pathogens. Interestingly, IL-13—a cytokine 
that co-localizes with CHI3L1, the IL-13 Rα2, and transmem-
brane protein TMEM219 to participate in a multimeric complex 
(47, 72)—was not detected in our short experimental timeframe 
(data not shown), while staphylococcal enterotoxins responsible 
for chronic infections have been reported (53). Future research 
exploring in-depth family members with chitinase enzymatic 
activity and other CLPs will further elucidate the mechanisms of 
inflammation in the infected mammary gland.
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